Related references
Note: Only part of the references are listed.Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
David Masopust et al.
JOURNAL OF IMMUNOLOGY (2014)
Mechanisms of Tumor Cell Necrosis
Sergey Y. Proskuryakov et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Superior Protective Immunity against Murine Listeriosis by Combined Vaccination with CpG DNA and Recombinant Salmonella enterica Serovar Typhimurium
Christina Berchtold et al.
INFECTION AND IMMUNITY (2009)
Salmonella type III-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
Klaus Panthel et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Less Yin, more Yang:: Confronting the barriers to cancer immunotherapy
Gregory Lizee et al.
CLINICAL CANCER RESEARCH (2007)
Prophylactic anti-tumor immunity against a murine fibrosarcoma triggered by the Salmonella type III secretion system
Klaus Panthel et al.
MICROBES AND INFECTION (2006)
Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells
Katharina M. Huster et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
TL Whiteside
SEMINARS IN CANCER BIOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Recent developments in therapeutic cancer vaccines
MA Morse et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets
KM Huster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Prognostic role of CD8+tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
F Prall et al.
HUMAN PATHOLOGY (2004)
Enteric pathogens as vaccine vectors for foreign antigen delivery
CN Kotton et al.
INFECTION AND IMMUNITY (2004)
Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells
ACP Diederichsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Monitoring immune responses in cancer patients receiving tumor vaccines
EB Walker et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2003)
Bacterial type III translocation:: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella
H Rüssmann
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Active-specific immunization against melanoma: Is the problem at the receiving end?
V Monsurro et al.
SEMINARS IN CANCER BIOLOGY (2003)
Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins
H Rüssmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Preferential localization of effector memory cells in nonlymphoid tissue
D Masopust et al.
SCIENCE (2001)
Use of live bacterial vaccine vectors for antigen delivery:: potential and limitations
E Medina et al.
VACCINE (2001)
Eradication of established tumors by CD8+ T cell adoptive immunotherapy
HL Hanson et al.
IMMUNITY (2000)
Share Paper
